TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

OBSIDIO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

OBSIDIO

ST13

US500000097646307

Classe

5, 10

Pedido

97646307

Registro

7681108

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

39

Atualização mais recente

04/02/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10

Data de depósito

25/10/2022

Data de registro

04/02/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

04/02/2025

Última transação

04/02/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

2023-05-00

Primeiro uso no comércio

2023-05-00

Código do desenho

4

Tipo de titular

03

Localização do titular

Maple Grove, MN, US

Examinador

DAWE III, BILL

Unidade examinadora

L80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Boston Scientific Scimed, Inc.

Representantes

Lori A. Ruhly Quarles & Brady LLP

Classificação técnica

Classes Nice

Classe 5Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for implantable hydrogel-based embolics; pharmaceutical preparations, namely, embolization therapy preparations for embolization of tumors; medical preparations for embolization therapy systems for the treatment of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; medical preparations for vascular embolization, hemorrhage control, and peripheral hemostasis; medical preparations used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; pharmaceutical preparations, namely, differentiated liquid embolic agents for embolization of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials comprised of artificial materials, namely, hydrogels; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materials, namely, hydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materials, namely, hydrogels; preparations for implantable surgical materials in the nature of implants comprised of artificial materials, namely, hydrogels

Classe 10

Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for use in embolization surgery; medical device, namely, arterial embolectomy device in the nature of catheters for use in embolectomy; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; medical apparatus, namely, system for vascular embolization procedures in the nature of catheters for use in embolectomy

Publicações

Histórico de despachos e eventos da marca no USPTO.

39 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/02/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/02/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

14/01/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

14/01/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/01/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

14/01/2025

ALIE

ASSIGNED TO LIE

13/01/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/12/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

16/09/2024

GNRT

NON-FINAL ACTION E-MAILED

16/09/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

16/09/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

13/09/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/09/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/09/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/09/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/09/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/09/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/09/2024

IUAF

USE AMENDMENT FILED

10/07/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/07/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

16/01/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

21/11/2023

PUBO

PUBLISHED FOR OPPOSITION

21/11/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/11/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/10/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/10/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

13/07/2023

GNRT

NON-FINAL ACTION E-MAILED

13/07/2023

CNRT

NON-FINAL ACTION WRITTEN

13/07/2023

DOCK

ASSIGNED TO EXAMINER

12/07/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

16/03/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

16/03/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

16/03/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

16/03/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

16/03/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/11/2022

NWAP

NEW APPLICATION ENTERED

28/10/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace OBSIDIO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.